Jump to Header Jump to Main Content Jump to Footer

trials found matching your search:


Displaying 20 of 267 Results
Age
Type
Conditions or Disease:

PhI Efficacy of Single&Multiple Doses of Oral AdminHS-10382 (TERN-701) in Ps w/Chronic Myeloid Leuk

Richard Van Etten

  • OPEN TO ACCRUAL

Risk-ADAPTed Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation (ADAPT)

Stefan Octavian Ciurea

  • OPEN TO ACCRUAL

PhI Ven/Aza Comb.w/ Ziftomenib or Cytarabine/Daunorubicin Comb.w/ Ziftomenib for Tx of Pts w/ AML

Deepa Jeyakumar

  • OPEN TO ACCRUAL

PhIII Odronextamab Comb w/CHOP vs Rituximab Comb w/CHOP in Prev Untrx Pts w/Diffuse Large Bcell Lymp

Elizabeth A Brem

  • OPEN TO ACCRUAL

PhII/III NABPLAGEMvsNabPaclitaxel/Gemcitabine BRCA1/2PALB2MutantMetaPancreaticDuctalAdenoCa

Jennifer Brooke Valerin

  • OPEN TO ACCRUAL

PhI BI 1810631 as Monotherapy in Pts w/ Adv or Metastatic Solid Tumors w/ HER2 Aberrations

Misako Nagasaka

  • OPEN TO ACCRUAL

Long-Term Follow-Up Study of Risdiplam in Participants With Spinal Muscular Atrophy (SMA)

Manisha Korb

  • OPEN TO ACCRUAL

Study of Oral FT-4202, a Pyruvate Kinase Agonist in Patients with Sickle Cell Disease (Hibiscus)

Zahra Pakbaz

  • OPEN TO ACCRUAL

Observational Study of Pts w/ R/R DLBCL 2nd or 3rd-Line Therapy & Not Receiving ASCT

Elizabeth A Brem

  • OPEN TO ACCRUAL

Safety and efficacy of AB-1003 in subjects (ages 18-65) with LGMD2I/R9 impacting FKRP

Tahseen Mozaffar

  • OPEN TO ACCRUAL

Ph1 MuSK-CAART for subjects with Anti-MuSK-antibody-positive MG

Ali Habib

  • OPEN TO ACCRUAL

A Phase Ia/Ib Study of LY3537982 in Patients with KRAS G12C-Mutant Advanced Solid Tumors

Misako Nagasaka

  • OPEN TO ACCRUAL

R5459-RT-1944: Study for Desensitization of Chronic Kidney Disease in Adult Patients in Need of a Ki

Robert Redfield III

  • OPEN TO ACCRUAL

PhI/IINivolumab+-Ipilimumabw/MultiFractionStereotacticRadiosurRecurHighGradeRadiationRelapsedMeningi

Aaron Simon

  • OPEN TO ACCRUAL